Companies or individuals wishing to submit a listing to appear on this page must submit the text to marcel@tmta.ca

Individuals interested in career opportunities listed on this page are asked to refrain from forwarding personal résumés to TMTA or contacting us directly about the job in question. The same caution applies to those responding to business opportunities listed here.

In both cases, please contact the individual or company whose coordinates appear in the listing.
 

Thanks to INO, light technology is now available
for a range of industry applications

Quebec-based INO (Institut national d'optique- National Optics Institute) is Canada’s leading center of expertise in industrial applications for optics/photonics. As the home of the largest concentration of skills in the field, INO explores and commercializes a variety of technologies and innovative processes. As such, the firm serves clients of all sizes across Canada and around the world. INO's assets represent unique business opportunities for companies looking for innovative technologies to bring to the market place. These technology transfers are carried out mainly through licensing or intellectual property sales.

A key area of application for light technologies involves the detection of listeria contamination, a serious source for concern in the food industry. A solution in the fight against this infection now comes to us from a Quebec-based institute called INO (Institut national d'optique).

INO has just been selected by the Ontario Center of Excellence (along with 4 other firms from a group of 20 candidates) to conduct a feasibility study on various technologies to be used for to identify the listeria bacterium. The INO project will specifically focus on the Institute's optical cells reader platform .

Depending on results, OCE will invest in finalizing a system slightly different from the one INO has developed.  OCE may invest up to  $200,000 per year for a 3 year period. The money available through OCE is for the development of a fast solution to Listeria identification, but since the system to be developed involves a cell reader, it will be possible to use this same reader for other applications involving cells identification and counting by using the appropriate assay.

One part of the project that has been accepted will involve the development of a sensitive assay and it will be conducted by Ms. Sue Chen from LabServices, an INO partner in the project.  Industry partners participating in the project will be required to match OCE investments in cash and in-kind contributions to the project. INO is actively looking for a manufacturer that would like to participate in this project.

For the complete list of technologies available for transfer, get in touch with TMTA by writing to marcel@tmta.ca
 
 

A U.S.-based manufacturer of high quality oral fluid collection devices , swabs and a variety of other medical diagnostic products, is seeking qualified distribution partners in Canada.

If such products are of interest to you and are in line with your current and/or future distribution channels of/for products, this company would welcome your inquiries.

For further information about this business opportunity, write to marcel@tmta.ca

A German medical device company specialized in the development and distribution of surgical bone implants and instruments is looking for a partner company in Canada.

Founded in 2000, this young company is already well respected by surgeons and hospitals throughout Europe and the world because its products offer the right mix of high quality and competitive pricing.

Professionals with decades of experience are responsible for product development and manufacturing is handled by companies with an outstanding reputation as providers for major established companies in the field. Last but not least, the company’s marketing and sales is excellent and very successful.

For further information about this business opportunity, write to marcel@tmta.ca

MPH Medical Devices, is a Czech company and a leader in OEM production of disposable medical devices in Europe. MPH focuses on the production of bloodlines, infusions, cannulae, dialysis equipment, etc.  All MPH products are made of plastics (PVC, PE PP, ABS, PU PC, etc). The company also offers a wide range of expertise services including product development, tubing, component injection molding, stock and transportation around Europe.

The company has more than 15 years of experience in the industry, about 270 employees and production sites totaling about 21, 500 ft which meet the highest standards of the medical industry. MPH devices have established an IS) 13485:2003 Quality Management system as well as directive 93/42/EEC and IS0 9001.

MPH management is looking to partner with North American companies looking to explore and expand into European markets. Interested parties should contact Jan Rechtacek, Director of CzechTrade Toronto at 416.848.4984 or toronto@czechtrade.cz

My name is Nick Gaddum and I am a New Zealand national living in Australia completing a PhD in medical engineering.  I am interested in working in Ontario for a company developing medical devices or an organisation with a bioengineering R&D department.

I work best at the leading edge of bioengineering research. I enjoy the proximity to both mechanical design and biological systems and the associated scope for development in this field. Energetic and thorough in my work, I enjoy both solo and team projects. Planning has always been an important part of my research and has allowed me to complete a three and a half year artificial heart design program.

After exploring biomechanical projects in my Bachelor’s Degree, I received a scholarship for a PhD program developing artificial hearts. During the program, my work has encompassed a range of investigative techniques for mechanical device design. These include computational analysis, software development; computer aided design, prototype development as well as both in vitro and in vivo testing.

From the research a Bi-Ventricular Assist Device, BiVAD, prototype was constructed and tested which incorporates a passive controller. Additionally, I wrote software to generate rotary pump geometries. Parallel to the experimental work, I developed a flexible numerical program with which to model a supported cardiovascular system. A thesis is now being compiled with a number of articles yet to be written in the following months.

I am seeking employment with an innovative group interested in merging mechanical
engineering with bioengineering. I will be available to commence work in early 2009. I can be reached at nickgaddum@gmail.com
 

Contacting TMTA was suggested to me by at the Life Sciences Council of the Buffalo Niagara Enterprise.  I am a business development professional and an entrepreneur with many years of experience in the Life Science industry.

I am presenlty working with a group that is launching a third party logistics company focused on providing GMP quality warehousing, inventory management, kit assembly, order fulfillment and distribution services specifically for Life Science companies.  We are planning to be operational in May 2008, and we are pre-selling space and services at reduced rates to companies that have an interest in doing business in western New York.

Our offering is unique because it caters to international Life Science companies – it complies with US regulatory guidelines for cGMP, we offer US agent services to international clients, and being less than 10 miles from the US/Canada border, we can help you to establish a US address for your business and we can facilitate fast and effective penetration of the US market.

If you have an interest in our business and its capabilities, or if you have suppliers, customers, or colleagues who may have an interest, please reply via e-mail or give me a call to schedule a more thorough discussion.

Vic Nole, Business Advisor, Nole Management, LLC
(716) 773-5680 office  (716) 310-5288 mobile
vic@nolemgt.com